[23 cases of severe bullous toxicoderma with necroepidermolysis. A major risk of delayed-action anti-infective and multiple-drug preparations: Debré-Lamy-Lamotte-Malcar syndrome, later named Lyell's syndrome].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003692:Delayed-Action Preparations; D004347:Drug Interactions; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008875:Middle Aged; D013262:Stevens-Johnson Syndrome; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D003692:Delayed-Action Preparations; D013449:Sulfonamides
A propos de 23 cas de toxidermies bulleuses sévères avec nécroépidermolyse. Un des risques majeurs des anti-infectieux retards et des plurimédications: syndrome de Debré, Lamy, Lamotte, Malcar, post-nommé syndrome de Lyell.